Fosters stays with Commander

Australian beer and wine giant Fosters has renewed a contract with Commander for the provision of managed services under the junior telco and integrator's Volante brand. Fosters' technology chief -- global director, Business Processes and IT, Andrew Leyden -- was not immediately available to comment on the deal, disclosed by Commander in an announcement to the Australian Stock Exchange this morning.

Australian beer and wine giant Fosters has renewed a contract with Commander for the provision of managed services under the junior telco and integrator's Volante brand.

Fosters' technology chief -- global director, Business Processes and IT, Andrew Leyden -- was not immediately available to comment on the deal, disclosed by Commander in an announcement to the Australian Stock Exchange this morning.

Speaking with ZDNet Australia this afternoon, Commander chief executive Adrian Coote declined to comment on the specifics of the Fosters arrangement.

When Commander first won the work in April 2005, the company said in a statement that the contract was "subject to confidentiality and non-disclosure agreements".

At the time, the integrator noted the contract had "significant business implications" for Commander, and considerably enhanced financial guidance given on the company's expansion into enterprise managed services.

The value of the Fosters deal was listed at that time as being variable, based on the volume of services performed by Commander over a two-year period.

Fosters operates some of Australia's largest beer brands, including Victoria Bitter and Crown Lager, and also has a significant business in wine -- with brands such as Wolf Blass, Penfolds, Rosemount, Yellowglen and Lindemans. The group has some 6,200 staff located in Australia and internationally.

Fosters' Leyden is relatively new to the top IT job, having been appointed after the group's former chief information officer Ian Farnsworth left the company late last year.

This morning, Commander also said it had recently found favour with pharmaceutical company Alphapharm and the South Australian state government.

Newsletters

You have been successfully signed up. To sign up for more newsletters or to manage your account, visit the Newsletter Subscription Center.
See All
See All